Abstract

BackgroundSentinel lymph node biopsy (SLNB) has been accepted as the standard treatment for axillary evaluation for invasive breast cancer with a clinically negative axilla and the low rate of recu...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call